Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen.

Presently, the assay that attains maximal sensitivity and dynamic range of HIV-1 viral copy number (50 copies per milliliter) is nucleic acid amplification of HIV RNA in plasma. Enzyme-linked immunosorbent assay (ELISA) methods for quantification of HIV-1 p24 antigen have been relatively insensitive. In this report, we show data that indicate real-time immuno-polymerase chain reaction (IPCR), a combination of the ELISA and PCR techniques, is more sensitive for HIV-1 p24 antigen detection than other currently reported methods. When derived from an IPCR standard curve, a dose response was observed from patient samples with known viral loads diluted within a 3-log range (1.68-6,514 viral RNA copies per milliliter). IPCR detected 42% (22/52) of patient samples that had fewer than 50 viral RNA copies per milliliter by reverse transcriptase-PCR. IPCR shows the potential to become the most analytically sensitive test available for determination of HIV-1 viral load by the detection of HIV-1 p24 antigen.

[1]  S. Hammer.  Advances in antiretroviral therapy and viral load monitoring. , 1996, AIDS.

[2]  D. Samuel,et al.  A quantitative immuno-PCR assay for the detection of mumps-specific IgG. , 2002, Journal of immunological methods.

[3]  P. Krijnen,et al.  Predictors of rapid progression to AIDS in HIV-1 seroconverters. , 1993, AIDS.

[4]  D. Vlahov,et al.  Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease. , 2002, The Journal of infectious diseases.

[5]  S. J. Clark,et al.  Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[6]  L. Mimms,et al.  Significant Closure of the Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Preseroconversion Detection Windows with a Transcription-Mediated-Amplification-Driven Assay , 2002, Journal of Clinical Microbiology.

[7]  D. Samuel,et al.  Development of a quantitative immuno-PCR assay and its use to detect mumps-specific IgG in serum. , 2002, Journal of immunological methods.

[8]  J. Böni,et al.  Heat‐mediated immune complex dissociation and enzyme‐linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV‐1 RNA detection by polymerase chain reaction , 1996, AIDS.

[9]  Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution‐state structure of the nucleocapsid protein from HIV‐1 , 1992, Protein science : a publication of the Protein Society.

[10]  B. Taiwo,et al.  Primary Human Immunodeficiency Virus , 2002, Southern medical journal.

[11]  S. Yerly,et al.  Cell-associated HIV-1 RNA in blood as indicator of virus load in lymph nodes. The Swiss HIV Cohort Study. , 1999, The Journal of infectious diseases.

[12]  Lawrence Corey,et al.  Biological and Virologic Characteristics of Primary HIV Infection , 1998, Annals of Internal Medicine.

[13]  Jörg Schüpbach,et al.  Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA. , 2002, AIDS reviews.

[14]  T V Perneger,et al.  Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia , 2000, AIDS.

[15]  A. Sönnerborg,et al.  Antigen detection in primary HIV infection , 1988, British medical journal.

[16]  J. Böni,et al.  Simple monitoring of antiretroviral therapy with a signal‐amplification‐boosted HIV‐1 p24 antigen assay with heat‐denatured plasma , 1997, AIDS.

[17]  R. Detels,et al.  A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. , 1990, The Journal of infectious diseases.

[18]  E. Scheibel,et al.  Clinical course of primary HIV infection: consequences for subsequent course of infection. , 1989, BMJ.

[19]  Anne McKie,et al.  Novel methods for the detection of microbial antibodies in oral fluid. , 2002, The Lancet. Infectious diseases.

[20]  G. Boiteau,et al.  J. Virol. Methods , 1996, Journal of Virological Methods.

[21]  J. Jackson,et al.  A modified ultrasensitive assay to detect quantified HIV-1 RNA of fewer than 50 copies per milliliter. , 2003, American journal of clinical pathology.

[22]  B. Ledergerber,et al.  Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failure. , 2000, International journal of antimicrobial agents.

[23]  J Schüpbach,et al.  Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement. , 2000, The Journal of infectious diseases.

[24]  H. Günthard,et al.  HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy. , 2003, Journal of acquired immune deficiency syndromes.

[25]  Susan Little,et al.  Diagnosis of Primary HIV-1 Infection , 2001, Annals of Internal Medicine.

[26]  S. Kleinman,et al.  Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. , 2000, Transfusion.

[27]  G. Satten,et al.  Duration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody , 1994, Transfusion.

[28]  J. Allain.  Will genome detection replace serology in blood screening for microbial agents? , 2000, Baillière's Best Practice & Research: Clinical Haematology.

[29]  A. Karlsson,et al.  Does symptomatic primary HIV-1 infection accelerate progression to CDC stage IV disease, CD4 count below 200 × 106/l, AIDS, and death from AIDS? , 1994, BMJ.

[30]  J. Böni,et al.  Quantitative and sensitive detection of immune-complexed and free HIV antigen after boiling of serum. , 1993, Journal of virological methods.

[31]  H. Joller,et al.  Antiretroviral treatment monitoring with an improved HIV‐1 p24 antigen test: an inexpensive alternative to tests for viral RNA , 2001, Journal of medical virology.